Antibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Research Highlight - ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks.
doi.org/10.1093/abt/...
#immunoadhesins #mabs